Bengaluru-based Altem Technologies, the provider of 3D printing solutions, has partnered with US-based CELLINK, a bioink company, to accelerate life-science research with 3D Bioprinting in the Indian market. With this partnership, Altem intends to establish a strong presence of bioprinting in the field of medical research and life science applications. 

The partnership with Altem enables Cellink to expand its footprint in the Indian market, providing bioprinting knowhow to researchers to conduct in-vitro studies and reduce the product development time of drugs and medicines. 

Sharath Chandra, Co-founding Director, Altem Technologies, said, “Through this partnership, we invest in making strategic efforts in identifying and nurturing the 3DBioprinting development opportunities for India. The outcome of this partnership will be to engage and respond to future trends of medicine and healthcare with bio convergence solutions”.

Cecilia Edebo, CEO/ MD, CELLINK Bioprinting said, “The convergence of robotics-AI-genomics-bioprinting can contribute to improved quality and future of healthcare. Given the larger addressable population and growing demands for precision medicine, there is a pressing need for addressing the healthcare requirements on priority and calls for accelerated research on the future of healthcare. Our Partnership with Altem will contribute in the direction of developing the technology of tomorrow for creating a better quality of life.”